Holland Capital Invests in Curess
Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be achieved.
Systemic Family Support
Curess offers specialized ambulatory youth care (such as intensive systemic guidance, ambulatory emergency help, perspective research, and co-parenting investigations) and focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organization achieves this by applying self-developed software that supports core processes (such as planning) and thus reduces administrative pressure.
Strategic Parntership
With this strategic partnership, Curess has found a partner to achieve its ambitious strategic goals.
Eddy de Bruin, CEO of Curess, states: “With the support of Holland Capital, we can realize our ambitions and help even more young people and families. With their expertise and resources, we are better equipped to significantly increase our impact in youth care. We are committed to providing the necessary support to families to learn to live together better, without waiting lists, through our dedicated professionals.”
Margot Engels, Healthcare Partner at Holland Capital, adds: “We are proud to add Curess to our portfolio. Curess provides crucial support to families in an innovative way, and we look forward to working together on their growth ambitions and further professionalization of their services. Our shared vision is to provide the best possible care and support.”
About Curess
With over 200 registered professionals, Curess offers specialized ambulatory youth care to young people and families to ensure they can live together better. By utilizing personal and innovative methods, Curess strives for a safe and supportive environment for children and their families. Curess is active in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.
The participation in Curess fits within Holland Capital’s strategy to invest in companies that contribute to societal challenges and create value for society. With this investment, Holland Capital takes an important step in further strengthening its portfolio within the healthcare sector.
Axual raises growth financing from investor Holland Capital
Axual raises growth financing from investor Holland Capital Utrecht/Amsterdam, 10 March 2022 - Holland Capital is investing with a private co-investor in software company Axual, which provides customers with a platform that makes real-time data streaming easier and...
Holland Capital investeert in Appronto; intensieve samenwerking met Magnus Digital, Dimensys, cards PLM solutions
Amsterdam – 3 februari 2022, Holland Capital investeert in Appronto, een dienstverlener van low-code en integratie oplossingen. De onderneming gaat nauw samenwerken met een drietal andere portfolio ondernemingen, te weten Magnus Digital, Dimensys en cards PLM...
Holland Capital acquires Appronto; extensive collaboration with Magnus Digital, Dimensys, and cards PLM solutions.
Holland Capital acquires Appronto; extensive collaboration with Magnus Digital, Dimensys, and cards PLM solutions 3 February 2022, Holland Capital acquires Appronto, a low-code and integration solutions service provider. The company will closely collaborate with three...
New investment for Prolira for roll-out smart-AI brain state monitor for the hospital market
New investment for Prolira for roll-out smart-AI brain state monitor for the hospital market Utrecht, 1 February 2022 – Holland Capital invests, together with Borski fund, ROM Utrecht Region, Health Innovations and Oost NL, in Prolira BV, the Dutch scale up that helps...
New investment for Prolira for roll-out smart-AI brain state monitor for the hospital market
New investment for Prolira for roll-out of EEG-based brain state monitor for the hospital market Utrecht, 1 February 2022 – Holland Capital invests, together with Borski fund, ROM Utrecht Region, Health Innovations and Oost NL, in Prolira BV, the Dutch scale up that...
New investment for Prolira for roll-out of EEG-based brain state monitor for the hospital market
New investment for Prolira for roll-out of EEG-based brain state monitor for the hospital market Utrecht, 26 January 2022 – Holland Capital invests, together with Borski fund, ROM Utrecht Region, Health Innovations and Oost NL, in Prolira BV, the Dutch scale up that...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl